GMMA
Neisseria meningitidis
Salmonella
fHbp
Journal
Pathogens (Basel, Switzerland)
ISSN: 2076-0817
Titre abrégé: Pathogens
Pays: Switzerland
ID NLM: 101596317
Informations de publication
Date de publication:
09 Jun 2021
09 Jun 2021
Historique:
received:
30
04
2021
revised:
26
05
2021
accepted:
03
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
GMMA, outer membrane vesicles resulting from hyperblebbing mutated bacterial strains, are a versatile vaccine platform for displaying both homologous and heterologous antigens. Periplasmic expression is a popular technique for protein expression in the lumen of the blebs. However, the ability of internalized antigens to induce antibody responses has not been extensively investigated. Herein, the
Identifiants
pubmed: 34207575
pii: pathogens10060726
doi: 10.3390/pathogens10060726
pmc: PMC8229706
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Biol Chem. 2004 Jan 16;279(3):2069-76
pubmed: 14578354
Microbiol Mol Biol Rev. 2010 Mar;74(1):81-94
pubmed: 20197500
PLoS One. 2017 Jul 25;12(7):e0181508
pubmed: 28742866
EBioMedicine. 2017 Aug;22:164-172
pubmed: 28735965
Infect Immun. 2004 May;72(5):2528-37
pubmed: 15102760
Front Immunol. 2017 Dec 22;8:1884
pubmed: 29375556
Clin Vaccine Immunol. 2016 Apr 04;23(4):304-14
pubmed: 26865597
J Extracell Vesicles. 2013 May 06;2:
pubmed: 24009891
J Mol Biol. 2008 Jun 27;380(1):51-66
pubmed: 18511069
Hum Vaccin Immunother. 2014;10(6):1478-93
pubmed: 24804797
Vaccines (Basel). 2020 Sep 17;8(3):
pubmed: 32957610
Vaccine. 2016 Feb 17;34(8):1025-33
pubmed: 26801064
Vaccine. 2014 Jul 31;32(35):4376-4385
pubmed: 24370705
Infect Immun. 2009 Jan;77(1):472-84
pubmed: 19001078
J Bacteriol. 2006 Aug;188(15):5385-92
pubmed: 16855227
ACS Omega. 2017 Nov 30;2(11):8282-8289
pubmed: 30023580
Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10428-10433
pubmed: 30262653
Vaccine. 2017 Jan 11;35(3):419-426
pubmed: 27998639
J Biol Chem. 2014 Sep 5;289(36):24922-35
pubmed: 25023285
Appl Environ Microbiol. 2014 Sep;80(18):5854-65
pubmed: 25038093
FEMS Immunol Med Microbiol. 2003 Jul 15;37(2-3):99-104
pubmed: 12832112
Science. 2000 Mar 10;287(5459):1816-20
pubmed: 10710308
Infect Immun. 2011 Feb;79(2):887-94
pubmed: 21115718
PLoS Negl Trop Dis. 2017 Jan 5;11(1):e0005118
pubmed: 28056035
PLoS One. 2012;7(6):e35616
pubmed: 22701551
J Control Release. 2020 Jul 10;323:253-268
pubmed: 32333919
Proteomics. 2006 Mar;6(6):1856-66
pubmed: 16456881
PLoS One. 2015 Aug 06;10(8):e0134478
pubmed: 26248044
J Biotechnol. 2015 Mar 20;198:46-52
pubmed: 25659926
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
pubmed: 10829079
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3099-104
pubmed: 20133740
Vaccine. 2014 May 13;32(23):2688-95
pubmed: 24704334
Int J Mol Sci. 2020 Jun 21;21(12):
pubmed: 32575921
Proteins. 2008 May 1;71(2):982-94
pubmed: 18004753
Carbohydr Res. 2014 Feb 19;385:1-8
pubmed: 24384528
Vaccines (Basel). 2021 Mar 06;9(3):
pubmed: 33800727
J Extracell Vesicles. 2014 Aug 11;3:
pubmed: 25147647
Semin Immunol. 2020 Aug;50:101433
pubmed: 33309166
Clin Vaccine Immunol. 2011 Mar;18(3):460-8
pubmed: 21248155
Methods Protoc. 2020 Aug 31;3(3):
pubmed: 32878036
Infect Immun. 2005 Feb;73(2):1151-60
pubmed: 15664958
Mol Cell Proteomics. 2006 Jan;5(1):144-56
pubmed: 16219938
Vaccine. 2010 Jul 5;28(30):4810-6
pubmed: 20483197
Front Immunol. 2019 Mar 08;10:335
pubmed: 30906291
Proteomics. 2009 Mar;9(6):1683-95
pubmed: 19294628
PLoS One. 2015 Oct 07;10(10):e0139847
pubmed: 26445460
Int J Med Microbiol. 2014 Nov;304(8):1032-7
pubmed: 25139826
J Infect Dis. 2009 Feb 1;199(3):326-35
pubmed: 19099487
Hum Vaccin Immunother. 2013 Jun;9(6):1241-53
pubmed: 23857274
Vaccine. 2009 Nov 12;27(48):6748-54
pubmed: 19748581
Mol Cell Proteomics. 2006 Apr;5(4):589-607
pubmed: 16399765